StockData
NeuroSense Therapeutics Ltd. logo

NeuroSense Therapeutics Ltd. (NRSN) stock

NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$1.37−0.14 (-9.27%)

Close on Nov 18, 2026Market cap $2.52MP/E –Yield –

NeuroSense Therapeutics total assets

Total assets on the balance sheet at the end of each period.

NeuroSense Therapeutics's total assets was $896.00K at Jun 30, 2026. For fiscal 2025 it was $1.03M, down 77.5% from the year before. The highest annual figure on record is $11.43M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.03M-77.5%
FY2024Dec 31, 2024$4.58M+43.6%
FY2023Dec 31, 2023$3.19M-58.7%
FY2022Dec 31, 2022$7.72M-32.5%
FY2021Dec 31, 2021$11.43M+1367.4%
FY2020Dec 31, 2020$779.00K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$896.00K-51.3%
Q4 FY2025Dec 31, 2025$1.03M-67.7%
Q2 FY2025Jun 30, 2025$1.68M-78.6%
Q4 FY2024Dec 31, 2024$4.58M-40.7%
Q2 FY2024Jun 30, 2024$1.84M-83.9%
Q4 FY2023Dec 31, 2023$3.19M-72.1%
Q2 FY2023Jun 30, 2023$7.87M+910.0%
Q4 FY2022Dec 31, 2022$7.72M–
Q2 FY2022Jun 30, 2022$11.45M–
Q4 FY2021Dec 31, 2021$11.43M–
Q4 FY2020Dec 31, 2020$779.00K–

More NeuroSense Therapeutics figures

See a number that looks wrong?